These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17891583)

  • 1. The effect of relative humidity on electrostatic charge decay of drugs and excipient used in dry powder inhaler formulation.
    Elajnaf A; Carter P; Rowley G
    Drug Dev Ind Pharm; 2007 Sep; 33(9):967-74. PubMed ID: 17891583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatic characterisation of inhaled powders: effect of contact surface and relative humidity.
    Elajnaf A; Carter P; Rowley G
    Eur J Pharm Sci; 2006 Dec; 29(5):375-84. PubMed ID: 16952450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of electrostatic charge decay in pharmaceutical powders and polymer materials used in dry powder inhaler devices.
    Carter PA; Rowley G; Fletcher EJ; Stylianopoulos V
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1083-8. PubMed ID: 9876564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems.
    Young PM; Sung A; Traini D; Kwok P; Chiou H; Chan HK
    Pharm Res; 2007 May; 24(5):963-70. PubMed ID: 17377746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics.
    Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
    J Pharm Sci; 2007 May; 96(5):1302-19. PubMed ID: 17455364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
    Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
    J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Electrostatic Behavior of Dry Powder-Inhaled Model Formulations.
    Jetzer MW; Morrical BD
    J Pharm Sci; 2019 Sep; 108(9):2949-2963. PubMed ID: 31004652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Relative Humidity on Bipolar Electrostatic Charge Profiles of dry Powder Aerosols.
    Yu J; Wong J; Ukkonen A; Kannosto J; Chan HK
    Pharm Res; 2017 Aug; 34(8):1707-1715. PubMed ID: 28540500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.
    Iida K; Hayakawa Y; Okamoto H; Danjo K; Luenberger H
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):444-6. PubMed ID: 15056961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations.
    Price R; Young PM; Edge S; Staniforth JN
    Int J Pharm; 2002 Oct; 246(1-2):47-59. PubMed ID: 12270608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®.
    Hoe S; Young PM; Traini D
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1365-75. PubMed ID: 21554161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.
    Kaialy W; Martin GP; Ticehurst MD; Royall P; Mohammad MA; Murphy J; Nokhodchi A
    AAPS J; 2011 Mar; 13(1):30-43. PubMed ID: 21057906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems.
    Hoe S; Traini D; Chan HK; Young PM
    Pharm Res; 2010 Jul; 27(7):1325-36. PubMed ID: 20354768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerodynamic and electrostatic properties of model dry powder aerosols: a comprehensive study of formulation factors.
    Telko MJ; Hickey AJ
    AAPS PharmSciTech; 2014 Dec; 15(6):1378-97. PubMed ID: 24938617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate.
    Xu Z; Mansour HM; Mulder T; McLean R; Langridge J; Hickey AJ
    J Pharm Sci; 2010 Aug; 99(8):3415-29. PubMed ID: 20222025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.